Structured self monitoring of blood glucose in Iranian people with type 2 diabetes; A cost consequence analysis

Abstract

BackgroundSelf-Monitoring of Blood Glucose (SMBG) is considered as a key factor in management of people with diabetes which is a growing and cost demanding health problem. The purpose of this study was to investigate the effect of comprehensive patient management using structured SMBG on metabolic control as well as its cost consequence analysis.MethodsSixty subjects were recruited in an observational study for a period of 6 months. They were provided with the ACCU-CHEK 360° View tool to fill in the values of the 7-point blood glucose profiles in three consecutive days during the study on a monthly basis. Changes in metabolic control were assessed by HbA1c and lipid profile measurement at the beginning and at the end of the study. In addition, cost consequence analysis was done considering different level of health care professionals with or without insurance coverage. The Average Cost Effectiveness Ratio (ACER) as well as Cost saving analysis were calculated and compared.ResultsThe analysis showed significant reduction in HbA1c during the 6-month period in all subjects (P = 0.000). Furthermore, a positive effect was observed on lipid profile. The cost of endocrinologist’s visit in private sector was estimated to be 265.76 USD while this figure was149.15 USD for general practitioner in public sector with insurance coverage. Total complications and mortality cost saving was 154.8 USD. The lowest ACER was calculated for intervention with general practitioner in public sector with insurance coverage.ConclusionStructured SMBG results in significant improvement of glycemic status. Moreover, it is more cost saving in public sector with insurance coverage. It seems that general practitioner visits with insurance coverage is the most affordable option for people with type 2 diabetes.

Development and validation of diabetes empowerment questionnaire in Iranian people with type 2 diabetes

“…Diabetes is a rapidly growing public health issue with significant social burden (Aghili et al. ). The estimated number of diabetic people was 366 million in 2011, an increase of more than 120 million since 2007.…”

Effect of Chromium on Glucose and Lipid Profiles in Patients with Type 2 Diabetes; A Meta-analysis Review of Randomized Trials

“…Diabetes mellitus (DM) is a serious health problem with the high financial and societal impression on health systems (1). A significant increase in costs of long-term treatment of diabetes and its complications is felt (2).…”

Biphasic insulin Aspart 30 vs. NPH plus regular human insulin in type 2 diabetes patients; a cost-effectiveness study

“…QALYs and number of reduction in hypoglycemic events were considered as outcomes and the incremental cost effectiveness ratio (ICER) per patient was calculated according to the below formula: ICER = ∆Cost/ ∆Outcome [ 26 , 27 ]. The comparison of ICERs per each outcome was held afterwards.…”

“…Type 2 diabetes mellitus (T2DM) is the most common metabolic disease in the world with highly cost-demanding complications [ 1 , 2 ]. Glycemic control is the mainstay of treatment in patients with diabetes mellitus and can be achieved via medical nutritional therapy [ 3 , 4 ], physical activity, oral medications, and insulin therapy [ 5 ].…”